The incorporation of the applicability domain by similarity assessment served a dual purpose: it enhanced the robustness of our predictions and allowed us to identify which novel compounds were most likely to exhibit desirable levels of biological activity. Consequently, this approach facilitated a more targeted and efficient selection of candidates for subsequent experimental validation.